|
|
Blood, 15 May 2005, Vol. 105, No. 10, pp. 3935-3938.
Prepublished online as a Blood First Edition Paper on February 1, 2005; DOI 10.1182/blood-2004-10-3955.
Previous Article | Next Article 
Submitted October 13, 2004
Accepted January 16, 2005
Deficiency in the p110 subunit of PI 3-kinase results in diminished Tie-2 expression and Tie-2-/--like vascular defects in mice
Etienne Lelievre, Pierre-Marie Bourbon, Li-Juan Duan, Robert L Nussbaum, and Guo-Hua Fong*
Center for Vascular Biology, Departments of Cell Biology, University of Connecticut Health Center, Farmington, CT, USA
Genetic Diseases Research Branch, NHGRI, National Institutes of Health, Bethesda, Maryland, USA
Center for Vascular Biology, Departments of Cell Biology, University of Connecticut Health Center, Farmington, CT, USA; Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, CT, USA
* Corresponding author; email: fong{at}nso2.uchc.edu.
Phosphoinositide 3-kinase (PI3K) is activated by transmembrane tyrosine kinases such as VEGF receptors and Tie-2, key regulators of vascular development. However, the in vivo role of PI3K during developmental vascularization remains to be defined. Here we demonstrate that mice deficient for the p110 catalytic subunit of PI3K display multiple vascular defects, including dilated vessels in the head, reduced branching morphogenesis in the endocardium, a lack of hierarchical order of large and small branches in the yolk sac, and impaired development of anterior cardinal veins. These vascular defects are strikingly similar to those in mice defective in the Tie-2 signaling pathway. Indeed, Tie-2 protein level was significantly lower in p110 deficient mice. Furthermore, RNA interference of p110 in cultured endothelial cells significantly reduced Tie-2 protein levels. These findings raise the possibility that PI3K may function as an upstream regulator of Tie-2 expression during mouse development.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Brouillard and M. Vikkula
Genetic causes of vascular malformations
Hum. Mol. Genet.,
October 15, 2007;
16(R2):
R140 - R149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Chang, G. K. Sukhova, P. Libby, E. Schvartz, A. H. Lichtenstein, S. J. Field, C. Kennedy, S. Madhavarapu, J. Luo, D. Wu, et al.
Deletion of the phosphoinositide 3-kinase p110{gamma} gene attenuates murine atherosclerosis
PNAS,
May 8, 2007;
104(19):
8077 - 8082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K Riley and K. H Moley
Glucose utilization and the PI3-K pathway: mechanisms for cell survival in preimplantation embryos.
Reproduction,
May 1, 2006;
131(5):
823 - 835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Riley, M. O. Carayannopoulos, A. H. Wyman, M. Chi, and K. H. Moley
Phosphatidylinositol 3-Kinase Activity Is Critical for Glucose Metabolism and Embryo Survival in Murine Blastocysts
J. Biol. Chem.,
March 3, 2006;
281(9):
6010 - 6019.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|